Prebiotic Inulin for Late-Reproductive Individuals
NCT07724522
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This study aims to evaluate the effects of 2 weeks of inulin supplementation in perimenopausal women with overweight or obesity. The primary questions this study seeks to answer are: Does 2 weeks of inulin supplementation alter the gut and vaginal estrobolome compared with placebo? Does 2 weeks of inulin supplementation affect cardiovascular health compared with placebo? Does 2 weeks of inulin supplementation affect skeletal muscle health compared with placebo?
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Obesity & Overweight
- Perimenopausal Women
- Prebiotics
- Inulin
- Muscle, Skeletal
- Cardiovascular Diseases (CVD)
- Microbiota
- Gastrointestinal Microbiome
- Dietary Fiber
- Women Health
- Vascular Health
- Insulin Resistance
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 40 to 55 years
- Sex
- Female
- Healthy volunteers
- Not accepted
- Sponsor
- George Washington University
- Last updated on ClinicalTrials.gov
- August 11, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
District of Columbia · 1
- Milken Institute School of Public Health · Washington D.C., DC
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.